Early research (Phase 1)Looking for participantsNCT05010564What this trial is testingTrivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)Who this might be right forLeukemia, B-Cell Baylor College of Medicine 38
Large-scale testing (Phase 3)Study completedNCT03734016What this trial is testingZanubrutinib (BGB-3111) Versus Ibrutinib in Participants With Relapsed/Refractory Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma BeiGene 652
Very early researchUnknownNCT03895944What this trial is testingET190L1-ARTEMIS™ T Cells in Relapsed, Refractory B Cell Leukemia and LymphomaWho this might be right forCD19+ Lymphoma, B-CellCD19+ Leukemia, B-Cell First Affiliated Hospital Xi'an Jiaotong University 18
Testing effectiveness (Phase 2)Study completedNCT00867529What this trial is testingRituximab in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant for Relapsed or Refractory B-cell LymphomaWho this might be right forB-cell Adult Acute Lymphoblastic LeukemiaB-cell Childhood Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic Leukemia+35 more Fred Hutchinson Cancer Center 63
Testing effectiveness (Phase 2)Study completedNCT00431873What this trial is testingA Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic LeukemiaWho this might be right forLymphocytic Leukemia, Chronic Mirati Therapeutics Inc. 21
Early research (Phase 1)Study completedNCT00003294What this trial is testingChemotherapy Given With Amifostine and Filgrastim in Treating Patients With Recurrent or Metastatic CancerWho this might be right forLeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific Roswell Park Cancer Institute 24
Testing effectiveness (Phase 2)Ended earlyNCT01500161What this trial is testingPooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-MatchWho this might be right forAcute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Lymphocytic Leukemia+6 more Texas Oncology Cancer Center 1
Testing effectiveness (Phase 2)Study completedNCT04605666What this trial is testingCD19-CAR-T2 Cells for CD19 Positive B Cell MalignanciesWho this might be right forB Cell LeukemiaB Cell Lymphoma Nanfang Hospital, Southern Medical University 77
Testing effectiveness (Phase 2)Study completedNCT00006251What this trial is testingFludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerWho this might be right forAcute Undifferentiated LeukemiaAdult Nasal Type Extranodal NK/T-cell LymphomaAnaplastic Large Cell Lymphoma+61 more Fred Hutchinson Cancer Center 21
Early research (Phase 1)Ended earlyNCT03320642What this trial is testingGRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host DiseaseWho this might be right forHematologic Malignancies Incyte Corporation 84
Early research (Phase 1)Study completedNCT00058227What this trial is testingAlvocidib, Fludarabine Phosphate, and Rituximab in Treating Patients With Lymphoproliferative Disorders or Mantle Cell LymphomaWho this might be right forB-cell Chronic Lymphocytic LeukemiaContiguous Stage II Grade 1 Follicular LymphomaContiguous Stage II Grade 2 Follicular Lymphoma+40 more National Cancer Institute (NCI) 37
Testing effectiveness (Phase 2)Study completedNCT01747486What this trial is testingDose Optimization Trial of CD19 Redirected Autologous T CellsWho this might be right forAdult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL University of Pennsylvania 42
Not applicableStudy completedNCT02582320What this trial is testingClinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient ProgramWho this might be right forChronic Lymphocytic Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 264
Early research (Phase 1)Study completedNCT00003166What this trial is testingBryostatin and Vincristine in B-Cell MalignanciesWho this might be right forRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Diffuse Mixed Cell Lymphoma+7 more National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)UnknownNCT02685670What this trial is testingCompetitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/LymphomaWho this might be right forHematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+19 more The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine 20
Large-scale testing (Phase 3)Study completedNCT00799461What this trial is testingInternet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late ComplicationsWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Large-scale testing (Phase 3)Study completedNCT02005471What this trial is testingEvaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Hoffmann-La Roche 389
Not applicableEnded earlyNCT00008216What this trial is testingBlood Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forAdult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more Columbia University 48
Testing effectiveness (Phase 2)Looking for participantsNCT04502394What this trial is testingSafety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLLWho this might be right forDiffuse Large B Cell LymphomaChronic Lymphocytic LeukemiaNon Hodgkin Lymphoma Kartos Therapeutics, Inc. 84
Testing effectiveness (Phase 2)Study completedNCT00003402What this trial is testingPeripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma or Chronic Lymphocytic LeukemiaWho this might be right forLeukemiaLymphoma University of Maryland, Baltimore 35